Interprétation des tests sérologiques : ne pas oublier le transfert passif des immunoglobulines !

Von Behring, 1890, On the acquisition of immunity against diptheria and tetanus in animals, Dtsch Med Wochensch, 16, 1145 Cohn, 1946, Preparation and properties of serum and plasma proteins, IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids, J Am Chem Soc, 68, 459, 10.1021/ja01207a034 Barandun, 1962, Intravenous administration of human γ-globulin, Vox Sang, 7, 157, 10.1111/j.1423-0410.1962.tb03240.x Späth, 2015, On the dark side of therapies with immunoglobulin concentrates: the adverse events, Front Immunol, 6, 11, 10.3389/fimmu.2015.00011 Izopet, 2015, Hepatitis E virus, Presse Med, 44, 328, 10.1016/j.lpm.2014.11.004 Benton, 2012, False-positive hepatitis B serology following IVIG therapy: forgotten but not gone!!, J Am Acad Dermatol, 66, e123, 10.1016/j.jaad.2011.03.032 Lichtiger, 1991, Spurious serologic test results in patients receiving infusions of intravenous immune gammaglobulin, Arch Pathol Lab Med, 115, 467 Pelloux, 1999, Intravenous immunoglobulin therapy: confounding effects on serological screening for toxoplasmosis during pregnancy, J Clin Microbiol, 37, 3423, 10.1128/JCM.37.10.3423-3424.1999 Rossi, 2002, Passively acquired treponemal antibody from intravenous immunoglobulin therapy in a pregnant patient, Arch Pathol Lab Med, 126, 1237, 10.5858/2002-126-1237-PATAFI Arnold, 2010, Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia, Transfusion (Paris), 50, 2577, 10.1111/j.1537-2995.2010.02766.x Kamili, 2009, Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model, Hepatology, 49, 1483, 10.1002/hep.22796 Zaaijer, 2008, Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection, J Med Virol, 80, 1344, 10.1002/jmv.21233 Wursthorn, 2010, Managing HBV in patients with impaired immunity, Gut, 59, 1430, 10.1136/gut.2009.195834